Susan Majka
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 28 | 2026 | 4103 | 2.500 |
Why?
| | Wnt Signaling Pathway | 6 | 2023 | 210 | 1.760 |
Why?
| | Capillaries | 2 | 2026 | 120 | 1.720 |
Why?
| | Pulmonary Alveoli | 2 | 2026 | 383 | 1.520 |
Why?
| | Neovascularization, Pathologic | 3 | 2025 | 284 | 1.460 |
Why?
| | Pulmonary Fibrosis | 5 | 2025 | 393 | 1.360 |
Why?
| | Neovascularization, Physiologic | 5 | 2026 | 191 | 1.340 |
Why?
| | Stem Cells | 14 | 2023 | 626 | 1.250 |
Why?
| | Hypertension, Pulmonary | 17 | 2022 | 1957 | 1.160 |
Why?
| | Adipocytes | 8 | 2025 | 223 | 1.150 |
Why?
| | Cell Separation | 6 | 2020 | 304 | 1.090 |
Why?
| | Endothelial Cells | 6 | 2026 | 866 | 1.060 |
Why?
| | Microvessels | 3 | 2025 | 98 | 0.980 |
Why?
| | Cell Lineage | 10 | 2020 | 377 | 0.930 |
Why?
| | Lung Injury | 5 | 2026 | 241 | 0.920 |
Why?
| | Cell Differentiation | 20 | 2025 | 2045 | 0.920 |
Why?
| | Endothelial Progenitor Cells | 2 | 2025 | 20 | 0.870 |
Why?
| | Adipose Tissue | 9 | 2022 | 644 | 0.830 |
Why?
| | Mice | 44 | 2026 | 18338 | 0.800 |
Why?
| | Stem Cell Niche | 3 | 2020 | 57 | 0.780 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 919 | 0.720 |
Why?
| | Animals | 59 | 2026 | 38141 | 0.720 |
Why?
| | beta Catenin | 3 | 2020 | 253 | 0.710 |
Why?
| | Endothelium, Vascular | 5 | 2020 | 951 | 0.670 |
Why?
| | Fibrosis | 4 | 2019 | 551 | 0.670 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 452 | 0.630 |
Why?
| | Myeloid Cells | 4 | 2019 | 146 | 0.620 |
Why?
| | Airway Remodeling | 1 | 2020 | 63 | 0.610 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.590 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 376 | 0.570 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 71 | 0.560 |
Why?
| | Immunophenotyping | 1 | 2020 | 320 | 0.560 |
Why?
| | Cells, Cultured | 15 | 2020 | 4127 | 0.550 |
Why?
| | Bone Marrow Cells | 7 | 2021 | 321 | 0.550 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 4 | 2017 | 51 | 0.550 |
Why?
| | Pericytes | 2 | 2017 | 37 | 0.540 |
Why?
| | PPAR gamma | 5 | 2022 | 178 | 0.530 |
Why?
| | Pulmonary Emphysema | 4 | 2026 | 277 | 0.510 |
Why?
| | Leukocyte Common Antigens | 5 | 2011 | 87 | 0.500 |
Why?
| | Pulmonary Artery | 11 | 2022 | 1127 | 0.480 |
Why?
| | Flow Cytometry | 7 | 2018 | 1156 | 0.470 |
Why?
| | Myocytes, Smooth Muscle | 7 | 2020 | 266 | 0.450 |
Why?
| | Cell- and Tissue-Based Therapy | 3 | 2016 | 78 | 0.450 |
Why?
| | Adipocytes, White | 2 | 2015 | 19 | 0.440 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2014 | 118 | 0.420 |
Why?
| | Mice, Inbred C57BL | 19 | 2025 | 5989 | 0.420 |
Why?
| | Mesoderm | 4 | 2010 | 147 | 0.410 |
Why?
| | Cell Proliferation | 9 | 2025 | 2499 | 0.400 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 82 | 0.390 |
Why?
| | Leptin | 3 | 2025 | 248 | 0.380 |
Why?
| | Lung Diseases | 4 | 2016 | 783 | 0.350 |
Why?
| | Bleomycin | 3 | 2019 | 253 | 0.350 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 441 | 0.340 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2011 | 272 | 0.330 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 29 | 0.330 |
Why?
| | Benzimidazoles | 2 | 2011 | 187 | 0.330 |
Why?
| | Mice, Transgenic | 12 | 2022 | 2189 | 0.330 |
Why?
| | Hematopoietic Stem Cells | 7 | 2025 | 419 | 0.330 |
Why?
| | Pulmonary Circulation | 3 | 2009 | 430 | 0.320 |
Why?
| | Intra-Abdominal Fat | 1 | 2011 | 100 | 0.320 |
Why?
| | Disease Models, Animal | 10 | 2026 | 4559 | 0.320 |
Why?
| | Osteoblasts | 1 | 2011 | 146 | 0.310 |
Why?
| | Fibroblast Growth Factor 10 | 3 | 2019 | 23 | 0.300 |
Why?
| | Familial Primary Pulmonary Hypertension | 5 | 2014 | 196 | 0.300 |
Why?
| | Osteogenesis | 1 | 2011 | 207 | 0.290 |
Why?
| | Humans | 43 | 2026 | 145491 | 0.290 |
Why?
| | Hypoxia | 9 | 2021 | 1199 | 0.280 |
Why?
| | Respiratory System | 1 | 2009 | 151 | 0.270 |
Why?
| | Regeneration | 5 | 2019 | 198 | 0.270 |
Why?
| | Phenotype | 7 | 2020 | 3157 | 0.260 |
Why?
| | Mice, Knockout | 7 | 2021 | 3125 | 0.240 |
Why?
| | Apoptosis | 4 | 2013 | 2411 | 0.240 |
Why?
| | Immunomodulation | 2 | 2021 | 99 | 0.240 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2026 | 61 | 0.230 |
Why?
| | Myofibroblasts | 2 | 2019 | 144 | 0.230 |
Why?
| | Anthracosis | 1 | 2025 | 14 | 0.230 |
Why?
| | Mutation | 2 | 2021 | 4093 | 0.230 |
Why?
| | Vasoconstriction | 2 | 2017 | 216 | 0.230 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2002 | 55 | 0.220 |
Why?
| | alpha 1-Antitrypsin | 1 | 2026 | 104 | 0.220 |
Why?
| | Superoxide Dismutase | 3 | 2014 | 303 | 0.220 |
Why?
| | Bronchiolitis | 1 | 2025 | 87 | 0.210 |
Why?
| | Arteries | 1 | 2026 | 261 | 0.210 |
Why?
| | Respiratory Mucosa | 2 | 2019 | 322 | 0.210 |
Why?
| | Vascular Remodeling | 3 | 2022 | 209 | 0.200 |
Why?
| | Pneumoconiosis | 1 | 2024 | 20 | 0.200 |
Why?
| | Coal Mining | 1 | 2024 | 23 | 0.200 |
Why?
| | Cell Line | 3 | 2020 | 2823 | 0.200 |
Why?
| | Smoke | 2 | 2025 | 148 | 0.200 |
Why?
| | Alveolar Epithelial Cells | 2 | 2025 | 120 | 0.190 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2023 | 2146 | 0.190 |
Why?
| | Muscle, Smooth, Vascular | 4 | 2015 | 444 | 0.190 |
Why?
| | Particulate Matter | 1 | 2025 | 337 | 0.190 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1996 | 0.180 |
Why?
| | Granuloma, Respiratory Tract | 1 | 2002 | 13 | 0.180 |
Why?
| | Cryptococcus neoformans | 1 | 2002 | 21 | 0.180 |
Why?
| | Cryptococcosis | 1 | 2002 | 31 | 0.180 |
Why?
| | Retinal Neovascularization | 1 | 2002 | 28 | 0.170 |
Why?
| | Insulin Resistance | 2 | 2025 | 1244 | 0.170 |
Why?
| | Epithelial Cells | 4 | 2020 | 1112 | 0.170 |
Why?
| | Cell Hypoxia | 2 | 2020 | 248 | 0.170 |
Why?
| | Urokinase-Type Plasminogen Activator | 2 | 1999 | 25 | 0.170 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 95 | 0.170 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2021 | 14 | 0.170 |
Why?
| | Hemopexin | 1 | 2021 | 38 | 0.170 |
Why?
| | Tamoxifen | 2 | 2019 | 191 | 0.170 |
Why?
| | Acute Lung Injury | 2 | 2017 | 301 | 0.160 |
Why?
| | Calgranulin B | 1 | 2020 | 10 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2022 | 101 | 0.160 |
Why?
| | Male | 21 | 2026 | 72817 | 0.160 |
Why?
| | Fibroblasts | 3 | 2018 | 1023 | 0.160 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2020 | 14 | 0.160 |
Why?
| | Myocardium | 4 | 2019 | 932 | 0.160 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 39 | 0.160 |
Why?
| | Occupational Exposure | 1 | 2024 | 355 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 907 | 0.150 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 34 | 0.150 |
Why?
| | Vascular System Injuries | 1 | 2020 | 81 | 0.150 |
Why?
| | Biomarkers | 5 | 2021 | 4283 | 0.150 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 28 | 0.150 |
Why?
| | Muscle, Skeletal | 3 | 2009 | 1794 | 0.150 |
Why?
| | Receptor, Serotonin, 5-HT2B | 1 | 2018 | 2 | 0.150 |
Why?
| | RNA Stability | 1 | 2020 | 119 | 0.140 |
Why?
| | Cell Culture Techniques | 2 | 2020 | 373 | 0.140 |
Why?
| | Myeloid Progenitor Cells | 1 | 2018 | 16 | 0.140 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 130 | 0.140 |
Why?
| | Female | 18 | 2025 | 78763 | 0.140 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 145 | 0.140 |
Why?
| | Benzaldehydes | 1 | 2017 | 11 | 0.130 |
Why?
| | Laryngostenosis | 1 | 2018 | 54 | 0.130 |
Why?
| | Cicatrix | 1 | 2018 | 70 | 0.130 |
Why?
| | Cadherins | 1 | 2019 | 200 | 0.130 |
Why?
| | Interleukin-17 | 1 | 2018 | 120 | 0.130 |
Why?
| | Membrane Proteins | 2 | 2022 | 1164 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2020 | 505 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2021 | 590 | 0.130 |
Why?
| | Niacinamide | 1 | 2017 | 87 | 0.130 |
Why?
| | Thiazolidinediones | 2 | 2009 | 139 | 0.130 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 277 | 0.130 |
Why?
| | Heart | 2 | 1999 | 626 | 0.130 |
Why?
| | Anemia, Sickle Cell | 1 | 2021 | 318 | 0.130 |
Why?
| | Integrin beta1 | 1 | 2017 | 33 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2002 | 1212 | 0.120 |
Why?
| | Protein Stability | 1 | 2017 | 178 | 0.120 |
Why?
| | MicroRNAs | 1 | 2022 | 689 | 0.120 |
Why?
| | Signal Transduction | 8 | 2019 | 5202 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 69 | 0.110 |
Why?
| | Hemoglobins | 2 | 2021 | 386 | 0.110 |
Why?
| | Trans-Activators | 1 | 1997 | 397 | 0.110 |
Why?
| | Gene Expression Regulation | 5 | 2022 | 2594 | 0.110 |
Why?
| | Promoter Regions, Genetic | 3 | 2015 | 1247 | 0.100 |
Why?
| | Repressor Proteins | 1 | 1997 | 430 | 0.100 |
Why?
| | Adult | 6 | 2025 | 40707 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 1997 | 620 | 0.100 |
Why?
| | Case-Control Studies | 5 | 2025 | 3619 | 0.100 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 294 | 0.100 |
Why?
| | Cell Fusion | 2 | 2015 | 48 | 0.100 |
Why?
| | Vascular Stiffness | 1 | 2018 | 486 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2355 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 2 | 2022 | 573 | 0.100 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2014 | 176 | 0.100 |
Why?
| | Inflammation | 3 | 2022 | 2883 | 0.100 |
Why?
| | Animals, Newborn | 2 | 2009 | 890 | 0.100 |
Why?
| | Macrophages | 3 | 2022 | 1509 | 0.100 |
Why?
| | Hydrogen Peroxide | 2 | 2012 | 338 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2018 | 1049 | 0.100 |
Why?
| | Aging | 1 | 2023 | 1940 | 0.090 |
Why?
| | Insulin | 2 | 2022 | 2506 | 0.090 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 79 | 0.090 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 8 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 975 | 0.090 |
Why?
| | Models, Biological | 4 | 2021 | 1815 | 0.090 |
Why?
| | ADAM Proteins | 2 | 2022 | 64 | 0.090 |
Why?
| | Early Growth Response Protein 1 | 2 | 2010 | 32 | 0.090 |
Why?
| | Cytological Techniques | 1 | 2011 | 28 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1216 | 0.090 |
Why?
| | Receptor, TIE-2 | 1 | 2011 | 11 | 0.090 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 206 | 0.090 |
Why?
| | Mice, Nude | 2 | 2011 | 678 | 0.090 |
Why?
| | Cell Adhesion | 2 | 2025 | 452 | 0.080 |
Why?
| | Ventricular Pressure | 1 | 2011 | 52 | 0.080 |
Why?
| | Regenerative Medicine | 1 | 2011 | 48 | 0.080 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 6 | 0.080 |
Why?
| | Osteocalcin | 1 | 2011 | 38 | 0.080 |
Why?
| | World Health Organization | 1 | 2011 | 104 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 751 | 0.080 |
Why?
| | Mice, Inbred ICR | 1 | 2011 | 113 | 0.080 |
Why?
| | Adipocytes, Brown | 1 | 2010 | 8 | 0.080 |
Why?
| | Diet, High-Fat | 1 | 2012 | 264 | 0.080 |
Why?
| | Cytogenetic Analysis | 1 | 2010 | 33 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2011 | 142 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 1997 | 1487 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 380 | 0.080 |
Why?
| | Extracellular Space | 1 | 2010 | 119 | 0.080 |
Why?
| | Lymphoid Progenitor Cells | 1 | 2009 | 11 | 0.080 |
Why?
| | Vascular Diseases | 1 | 2012 | 252 | 0.070 |
Why?
| | Bronchoconstriction | 1 | 2009 | 29 | 0.070 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1769 | 0.070 |
Why?
| | Syndecan-4 | 1 | 2009 | 6 | 0.070 |
Why?
| | Genotype | 2 | 2011 | 1853 | 0.070 |
Why?
| | Middle Aged | 6 | 2025 | 36176 | 0.070 |
Why?
| | AC133 Antigen | 1 | 2008 | 20 | 0.070 |
Why?
| | Giant Cells | 1 | 2008 | 21 | 0.070 |
Why?
| | Neprilysin | 1 | 2009 | 47 | 0.070 |
Why?
| | Ventricular Function, Right | 1 | 2011 | 296 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2009 | 2820 | 0.070 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2009 | 34 | 0.070 |
Why?
| | Muscle, Smooth | 1 | 2009 | 153 | 0.070 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 223 | 0.070 |
Why?
| | Hyperoxia | 1 | 2009 | 96 | 0.070 |
Why?
| | Infant, Newborn, Diseases | 1 | 2009 | 115 | 0.070 |
Why?
| | Young Adult | 2 | 2025 | 14192 | 0.070 |
Why?
| | Receptor for Advanced Glycation End Products | 2 | 2020 | 29 | 0.060 |
Why?
| | Vasodilator Agents | 1 | 2009 | 330 | 0.060 |
Why?
| | Thrombosis | 1 | 2011 | 401 | 0.060 |
Why?
| | Activating Transcription Factor 1 | 1 | 2006 | 9 | 0.060 |
Why?
| | Transcriptome | 2 | 2025 | 1038 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 17 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1710 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 33 | 0.060 |
Why?
| | Aged | 4 | 2025 | 26125 | 0.060 |
Why?
| | Glycoproteins | 1 | 2008 | 353 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 550 | 0.060 |
Why?
| | RNA, Small Interfering | 4 | 2011 | 632 | 0.060 |
Why?
| | Asia, Western | 1 | 2025 | 5 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2009 | 602 | 0.060 |
Why?
| | Smoking | 2 | 2025 | 1468 | 0.060 |
Why?
| | Bone Marrow Transplantation | 3 | 2019 | 297 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 593 | 0.060 |
Why?
| | Cytokines | 3 | 2021 | 2054 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 557 | 0.060 |
Why?
| | Hepatocytes | 1 | 2026 | 224 | 0.060 |
Why?
| | Inhalation Exposure | 1 | 2025 | 103 | 0.050 |
Why?
| | Smokers | 1 | 2025 | 137 | 0.050 |
Why?
| | Pyrroles | 2 | 2018 | 213 | 0.050 |
Why?
| | Ovariectomy | 1 | 2025 | 164 | 0.050 |
Why?
| | Adiponectin | 2 | 2022 | 240 | 0.050 |
Why?
| | Age Factors | 2 | 2010 | 3340 | 0.050 |
Why?
| | Sex Factors | 1 | 2010 | 2110 | 0.050 |
Why?
| | Coal | 1 | 2024 | 18 | 0.050 |
Why?
| | Silicates | 1 | 2024 | 19 | 0.050 |
Why?
| | Blotting, Western | 3 | 2012 | 1162 | 0.050 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2026 | 636 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2024 | 200 | 0.050 |
Why?
| | Dust | 1 | 2024 | 101 | 0.050 |
Why?
| | Muscle Cells | 1 | 2003 | 41 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2014 | 149 | 0.050 |
Why?
| | Guanine | 1 | 2003 | 85 | 0.050 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 242 | 0.050 |
Why?
| | Wound Healing | 2 | 2003 | 355 | 0.050 |
Why?
| | Sepsis | 1 | 2009 | 661 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2024 | 122 | 0.050 |
Why?
| | Peptides | 1 | 2008 | 993 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 839 | 0.050 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2002 | 14 | 0.050 |
Why?
| | Endothelium | 1 | 2003 | 119 | 0.050 |
Why?
| | Biopsy | 1 | 2025 | 1081 | 0.040 |
Why?
| | Stem Cell Transplantation | 4 | 2006 | 190 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 108 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.040 |
Why?
| | Indoles | 2 | 2018 | 508 | 0.040 |
Why?
| | ADAM17 Protein | 1 | 2002 | 42 | 0.040 |
Why?
| | Ceramides | 1 | 2022 | 117 | 0.040 |
Why?
| | Multipotent Stem Cells | 1 | 2002 | 21 | 0.040 |
Why?
| | In Situ Nick-End Labeling | 1 | 2002 | 120 | 0.040 |
Why?
| | Metalloendopeptidases | 1 | 2002 | 63 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2014 | 203 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2002 | 316 | 0.040 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 199 | 0.040 |
Why?
| | Quail | 2 | 1999 | 6 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2002 | 161 | 0.040 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2002 | 130 | 0.040 |
Why?
| | Heme | 1 | 2021 | 89 | 0.040 |
Why?
| | Phosphoproteins | 2 | 2017 | 339 | 0.040 |
Why?
| | Cell Division | 3 | 2009 | 753 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 295 | 0.040 |
Why?
| | Models, Animal | 1 | 2002 | 395 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2001 | 193 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 821 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 242 | 0.040 |
Why?
| | Vital Capacity | 1 | 2020 | 292 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 343 | 0.040 |
Why?
| | Rats | 3 | 2013 | 5581 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 379 | 0.040 |
Why?
| | Epithelium | 1 | 2020 | 310 | 0.040 |
Why?
| | Hepatocyte Growth Factor | 1 | 1999 | 33 | 0.040 |
Why?
| | Arterioles | 1 | 2018 | 52 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 3076 | 0.040 |
Why?
| | Quinazolines | 1 | 2020 | 266 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2020 | 762 | 0.030 |
Why?
| | Monocytes | 1 | 2021 | 536 | 0.030 |
Why?
| | Benzodioxoles | 1 | 2020 | 161 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2018 | 185 | 0.030 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 4 | 0.030 |
Why?
| | Transfection | 2 | 2013 | 925 | 0.030 |
Why?
| | DNA Primers | 2 | 2009 | 507 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1997 | 56 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 93 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2009 | 6437 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2017 | 196 | 0.030 |
Why?
| | Embryo, Nonmammalian | 1 | 1997 | 171 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 797 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 1 | 2018 | 238 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2013 | 2526 | 0.030 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.030 |
Why?
| | Blood Pressure | 2 | 2014 | 1782 | 0.030 |
Why?
| | Fibrin | 1 | 2017 | 84 | 0.030 |
Why?
| | Bioengineering | 1 | 2016 | 20 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 648 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2862 | 0.030 |
Why?
| | Hemodynamics | 2 | 2012 | 1116 | 0.030 |
Why?
| | RNA | 1 | 2002 | 929 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| | GTP Cyclohydrolase | 1 | 2014 | 10 | 0.030 |
Why?
| | Muscle Development | 2 | 2009 | 113 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 23 | 0.030 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 38 | 0.030 |
Why?
| | Estrogen Antagonists | 1 | 2014 | 37 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2014 | 90 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2017 | 426 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 754 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 855 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 11831 | 0.030 |
Why?
| | Genome, Human | 1 | 2016 | 420 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 2002 | 0.020 |
Why?
| | Veterans | 1 | 2025 | 1626 | 0.020 |
Why?
| | Monocrotaline | 1 | 2013 | 31 | 0.020 |
Why?
| | S100 Proteins | 1 | 2013 | 35 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 207 | 0.020 |
Why?
| | Glycation End Products, Advanced | 1 | 2013 | 41 | 0.020 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 32 | 0.020 |
Why?
| | Infusion Pumps | 1 | 2012 | 33 | 0.020 |
Why?
| | Chronic Disease | 2 | 2009 | 1816 | 0.020 |
Why?
| | Spin Labels | 1 | 2012 | 59 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2012 | 130 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2013 | 134 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2012 | 163 | 0.020 |
Why?
| | Societies, Medical | 1 | 2016 | 898 | 0.020 |
Why?
| | Cardiac Output | 1 | 2012 | 179 | 0.020 |
Why?
| | Rats, Inbred WKY | 1 | 2011 | 35 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1020 | 0.020 |
Why?
| | Free Radical Scavengers | 1 | 2011 | 82 | 0.020 |
Why?
| | Naphthalenes | 1 | 2011 | 56 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2013 | 205 | 0.020 |
Why?
| | Gene Expression | 2 | 2008 | 1478 | 0.020 |
Why?
| | Time Factors | 1 | 2002 | 7171 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 473 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 700 | 0.020 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2011 | 211 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 848 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 95 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2016 | 1378 | 0.020 |
Why?
| | Tyrosine | 1 | 2010 | 219 | 0.020 |
Why?
| | Transcription Factors | 1 | 1997 | 1733 | 0.020 |
Why?
| | Syndecan-3 | 1 | 2009 | 7 | 0.020 |
Why?
| | PAX7 Transcription Factor | 1 | 2009 | 13 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2011 | 436 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10874 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 120 | 0.020 |
Why?
| | Capillary Permeability | 1 | 2009 | 132 | 0.020 |
Why?
| | Child | 1 | 2008 | 22680 | 0.020 |
Why?
| | Neoplasms | 1 | 2003 | 2897 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 475 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2012 | 894 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2006 | 16 | 0.020 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2006 | 18 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 372 | 0.020 |
Why?
| | Collagenases | 1 | 2006 | 22 | 0.020 |
Why?
| | Blood Vessels | 1 | 2008 | 167 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2010 | 452 | 0.020 |
Why?
| | CD11 Antigens | 1 | 2006 | 29 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2006 | 36 | 0.020 |
Why?
| | Cell Movement | 1 | 2011 | 961 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1080 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2007 | 136 | 0.010 |
Why?
| | Adolescent | 1 | 2025 | 22485 | 0.010 |
Why?
| | Heart Failure | 1 | 2019 | 2329 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2012 | 1350 | 0.010 |
Why?
| | Antioxidants | 1 | 2009 | 549 | 0.010 |
Why?
| | Muscle Proteins | 1 | 2007 | 242 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2006 | 407 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1367 | 0.010 |
Why?
| | Base Sequence | 1 | 2008 | 2180 | 0.010 |
Why?
| | Dietary Fats | 1 | 2006 | 308 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1498 | 0.010 |
Why?
| | O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 6 | 0.010 |
Why?
| | Carmustine | 1 | 2003 | 52 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2003 | 115 | 0.010 |
Why?
| | Cell Survival | 1 | 2006 | 1094 | 0.010 |
Why?
| | Half-Life | 1 | 2003 | 153 | 0.010 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2003 | 72 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2003 | 72 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2006 | 733 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 2003 | 427 | 0.010 |
Why?
| | Molecular Probes | 1 | 2002 | 33 | 0.010 |
Why?
| | Radiation Chimera | 1 | 2001 | 27 | 0.010 |
Why?
| | Cell Transplantation | 1 | 2001 | 39 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 312 | 0.010 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2001 | 139 | 0.010 |
Why?
| | Myocardial Ischemia | 1 | 2001 | 287 | 0.010 |
Why?
| | Chick Embryo | 1 | 1999 | 132 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 519 | 0.010 |
Why?
| | United States | 1 | 2016 | 16115 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 651 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2006 | 1392 | 0.010 |
Why?
|
|
Majka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|